Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2026-06-22 16:50:00 ET · period of report 2026-06-18 · accession 0001628280-26-044694 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-22 16:50 | 2026-06-18 | BLFS | Mathew Aby J. | EVP, CSO | F - Tax | $26.04 | -564 | 389.0K | -0.1% | -$14.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-18 | F | D | 564 | $26.04 | 388,976 | D | — | — | (F1) Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |